EOLS – evolus, inc. (US:NASDAQ)

DELAYED
$ usd
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day EOLS SPY QQQ SPX
Date
Time
Symbol
Company Name
Action
%Chg
11/6/2024
04:05 pm
eols
evolus, inc.
MISS
-15.0%
7/31/2024
04:05 pm
eols
evolus, inc.
MISS
10.6%
5/7/2024
04:05 pm
eols
evolus, inc.
MISS
-1.2%
3/7/2024
04:05 pm
eols
evolus, inc.
MISS
-6.2%
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions?
The answers are right here.
Stock Stats
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Top News Gainers
6/4 Form 4/A Evolus, Inc. For: Jun 03 Filed by: Alphaeon Corp 16.7%
11/7 Evolus Announces Pricing of Public Offering of Common Stock 14.3%
7/17 Form 4 Evolus, Inc. For: Jul 15 Filed by: Parschauer Karah Herdman 11.6%
5/17 Form 424B4 Evolus, Inc. 8.0%
8/8 Juvly Aesthetics Continues Its Leadership Expansion with Appointment of a Chief People Officer 6.7%
2/25 Form 10-K Evolus, Inc. For: Dec 31 6.0%
5/21 ALPHAEON Corporation to Pay Off $88 million of Outstanding Third-Party Debt 5.4%
7/16 Form 8-K Evolus, Inc. For: Jul 15 4.8%
10/15 Evolus Inc (NASDAQ: EOLS) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 4.4%
5/31 Form 4 Evolus, Inc. For: May 31 Filed by: SILVERNAIL LAUREN P 4.2%
Top News Decliners
5/15 ALPHAEON Corporation sells 4 million shares in Evolus Inc. -11.2%
8/13 Evolus Inc (NASDAQ: EOLS) had its "outperform" rating re-affirmed by analysts at JMP Securities. They now have a $30.00 price target on the stock. -11.0%
3/17 Form DEF 14A Evolus, Inc. For: May 01 -10.7%
2/25 Q4/2019 12/31/2019 EPS -0.470 ZacksConsensus -0.850 ActVsEst 0.380 - Beat -8.6%
3/27 Evolus Inc (NASDAQ: EOLS) had its price target lowered by analysts at HC Wainwright from $31.00 to $16.00. They now have a "buy" rating on the stock. -8.0%
3/4 Evolus Provides Update on International Trade Commission (ITC) Case -7.7%
1/9 Form 8-K Evolus, Inc. For: Jan 09 -7.0%
1/10 Form 8-K Evolus, Inc. For: Jan 10 -6.8%
3/3 Evolus to Participate in Barclays 2020 Global Healthcare Conference -6.3%
8/12 Q2/2019 6/30/2019 EPS -1.370 ZacksConsensus -0.960 ActVsEst (0.410) - Miss -6.2%

Don’t Miss Out On The Next BIG Stock Move

Thanks for submitting the form.
EOLS – evolus, inc. (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
EOLS
SPY
QQQ
SPX
EOLS – evolus, inc. (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
EOLS SPY QQQ SPX
Stock Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Stock Stats
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
News
12/20
06:00 am
eols
Medium
Is Evolus, Inc. approaching profitability? [Yahoo! Finance]
12/13
04:05 pm
eols
Neutral
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/22
08:11 am
eols
Medium
COSMETIC EXECUTIVE WOMEN (CEW) HONORS THE BEST IN BEAUTY [Yahoo! Finance]
11/18
02:20 pm
eols
Low
Botox Competitor Jeuveau Launches A $49-A-Month Membership [Forbes]
11/18
11:38 am
eols
Low
Here's Why Evolus (EOLS) Could be Great Choice for a Bottom Fisher [Yahoo! Finance]
11/14
11:31 am
eols
Low
Down -29.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Evolus (EOLS) [Yahoo! Finance]
11/9
09:50 am
eols
Low
Earnings Update: Evolus, Inc. (NASDAQ:EOLS) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts [Yahoo! Finance]
11/7
08:36 am
eols
High
Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
11/7
06:17 am
eols
High
Evolus Inc (EOLS) Q3 2024 Earnings Call Highlights: Revenue Surge Amid Market Challenges [Yahoo! Finance]
11/6/2024
04:05 pm
eols
-15.0%
MISS
7/31/2024
04:05 pm
eols
10.6%
MISS
5/7/2024
04:05 pm
eols
-1.2%
MISS
3/7/2024
04:05 pm
eols
-6.2%
MISS
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions? The answers are right here.
11/7
08:36 am
Reiterates
Buy
Buy
HC Wainwright
High
-15.0%
11/1
08:15 am
Reiterates
Buy
Buy
HC Wainwright
Low
-1.3%
10/3
08:18 am
Reiterates
Buy
Buy
HC Wainwright
Low
-2.4%
12/26
05:28 pm
eols
Low
Form 4 Evolus, Inc. For: Dec 23 Filed by: MOATAZEDI DAVID
12/26
05:28 pm
eols
Low
Form 4 Evolus, Inc. For: Dec 23 Filed by: Avelar Rui
12/26
05:28 pm
eols
Low
Form 4 Evolus, Inc. For: Dec 23 Filed by: Beaver Sandra
11/14
04:55 pm
eols
Low
Form SCHEDULE 13G/A Evolus, Inc. Filed by: Nantahala Capital Management, LLC
11/14
04:51 pm
eols
Low
Form SC 13G/A Evolus, Inc. Filed by: PERCEPTIVE ADVISORS LLC
11/14
04:00 pm
eols
Low
Form SC 13G/A Evolus, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC
11/13
05:38 pm
eols
Low
Form SC 13G/A Evolus, Inc. Filed by: Stonepine Capital Management, LLC
11/6
05:23 pm
eols
High
Form S-8 Evolus, Inc.
11/6
04:38 pm
eols
Medium
Form 10-Q Evolus, Inc. For: Sep 30
Show more
Top News Gainers
6/4 Form 4/A Evolus, Inc. For: Jun 03 Filed by: Alphaeon Corp 16.7%
11/7 Evolus Announces Pricing of Public Offering of Common Stock 14.3%
7/17 Form 4 Evolus, Inc. For: Jul 15 Filed by: Parschauer Karah Herdman 11.6%
5/17 Form 424B4 Evolus, Inc. 8.0%
8/8 Juvly Aesthetics Continues Its Leadership Expansion with Appointment of a Chief People Officer 6.7%
2/25 Form 10-K Evolus, Inc. For: Dec 31 6.0%
5/21 ALPHAEON Corporation to Pay Off $88 million of Outstanding Third-Party Debt 5.4%
7/16 Form 8-K Evolus, Inc. For: Jul 15 4.8%
10/15 Evolus Inc (NASDAQ: EOLS) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 4.4%
5/31 Form 4 Evolus, Inc. For: May 31 Filed by: SILVERNAIL LAUREN P 4.2%
Top News Decliners
5/15 ALPHAEON Corporation sells 4 million shares in Evolus Inc. -11.2%
8/13 Evolus Inc (NASDAQ: EOLS) had its "outperform" rating re-affirmed by analysts at JMP Securities. They now have a $30.00 price target on the stock. -11.0%
3/17 Form DEF 14A Evolus, Inc. For: May 01 -10.7%
2/25 Q4/2019 12/31/2019 EPS -0.470 ZacksConsensus -0.850 ActVsEst 0.380 - Beat -8.6%
3/27 Evolus Inc (NASDAQ: EOLS) had its price target lowered by analysts at HC Wainwright from $31.00 to $16.00. They now have a "buy" rating on the stock. -8.0%
3/4 Evolus Provides Update on International Trade Commission (ITC) Case -7.7%
1/9 Form 8-K Evolus, Inc. For: Jan 09 -7.0%
1/10 Form 8-K Evolus, Inc. For: Jan 10 -6.8%
3/3 Evolus to Participate in Barclays 2020 Global Healthcare Conference -6.3%
8/12 Q2/2019 6/30/2019 EPS -1.370 ZacksConsensus -0.960 ActVsEst (0.410) - Miss -6.2%